
Results presented at the European Society for Medical Oncology meeting could help separate Roche’s medicine from similar hormone-degrading drugs for breast tumors.

Results presented at the European Society for Medical Oncology meeting could help separate Roche’s medicine from similar hormone-degrading drugs for breast tumors.
A pragmatic guide for CXOs in the healthcare and pharmaceutical industries Artificial intelligence is already…
A high-level meeting between Uganda and Egypt to strengthen pharmaceutical cooperation CAIRO, Egypt (AfricaNewswire.Net) —…
اجتماع رفيع المستوى بين أوغندا ومصر لتعزيز التعاون الصيدلاني القاهرة، مصر، نوفمبر 2024 (AfricaNewswire.Net) في…
Interface of retinal pigment epithelium and photoreceptor cells. Source: NIH Open-i As we discussed in our December 17, 2015…
Valued at $1.25 billion, the deal expands BioNTech’s cancer drug portfolio and heads off royalty costs it could have owed…
The Arc Institute has launched the Virtual Cell Challenge, a new open competition to benchmark computational models that predict how…
On January 12, 2018, Endpoints News sponsored a breakfast panel at the 2018 JP Morgan Healthcare Conference (JPM18) in San…
Sign in to your account